Concerta XL and Elvanse are the two most commonly prescribed long-acting ADHD medications in the UK. They work through different mechanisms, have different concentration profiles through the day, and affect sleep in different ways. Here is what the pharmacokinetic data shows.
Elvanse (lisdexamfetamine) is a prodrug that converts to d-amphetamine in the bloodstream. Concerta XL (methylphenidate) uses an osmotic release system (OROS) that delivers methylphenidate gradually through a laser-drilled hole in the tablet. These are fundamentally different medications that happen to treat the same condition.
Neither is objectively "better". They suit different people for different reasons. The choice between them is clinical, based on your response, your side effect profile, and your daily schedule.
Elvanse: Slow onset (peak at ~4 hours). Long, smooth tail (half-life ~10 hours). Total effective duration approximately 12 to 14 hours. The concentration curve is gradual: a long ramp up, a broad peak, and a slow decline.
Concerta XL: Faster initial onset due to an immediate-release coating (22% of the dose releases immediately). Peak at approximately 6 to 7 hours. Shorter half-life (~3.5 hours after peak). Total effective duration approximately 10 to 12 hours. The curve has a more defined peak and a steeper decline.
The key difference is the tail. Elvanse's d-amphetamine molecule has a half-life roughly three times longer than Concerta XL's methylphenidate. This means Elvanse provides longer coverage but keeps levels active later into the evening. Concerta XL fades faster, which can mean less afternoon coverage but easier wind-down for sleep. ADHDose models both profiles so you can see the difference on your own curve.
Elvanse's wind-down threshold typically occurs 12 to 14 hours after dosing. The exact time depends on your dose and metabolism, but for most people it falls in the evening. ADHDose calculates this for your specific situation.
Concerta XL's shorter half-life means levels drop below the equivalent threshold significantly earlier, often several hours before Elvanse would. For people who have difficulty winding down on Elvanse, Concerta XL may offer a noticeably earlier sleep window. The trade-off is shorter total coverage during the day.
However, Concerta XL's steeper decline can also mean a more noticeable "crash" as the medication wears off. Some people experience a rebound effect in the late afternoon where ADHD symptoms temporarily feel worse than baseline. Elvanse's slower decline makes this less pronounced for most people.
| Elvanse | Concerta XL | |
|---|---|---|
| Active molecule | d-amphetamine | Methylphenidate |
| Time to peak | ~4 hours | ~6-7 hours |
| Half-life | ~10 hours | ~3.5 hours |
| Duration | 12-14 hours | 10-12 hours |
| Wind-down timing | Late evening | Mid-to-late afternoon |
| Wear-off feel | Gradual fade | Steeper decline, possible rebound |
| Food interaction | Minimal effect | Must be swallowed whole |
If your specialist suggests switching from one to the other, the transition is typically straightforward. Most prescribers will stop one medication and start the other the following day, adjusting the dose based on clinical equivalence tables.
If you are tracking with ADHDose, switching medications gives you one of the clearest before-and-after comparisons possible. You can see exactly how your concentration profile, focus pattern, and sleep timing change on the new medication compared to the old one.
ADHDose models the concentration curve for both Concerta XL and Elvanse, based on your actual dose and timing.
Download ADHDose